{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:43:03Z","timestamp":1794663783060,"version":"4.9.1"},"reference-count":70,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-159533"],"award-info":[{"award-number":["PJT-159533"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Heart and Stroke Foundation of Canada\u2019s National New Investigator Award"},{"name":"Lorna Jocelyn Wood Chair in Kidney Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Primary aldosteronism (PA) is one of the most common causes of secondary hypertension, but the comparative outcomes of targeted treatment remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare the clinical outcomes in patients treated for primary aldosteronism over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Medline and EMBASE were searched. Original studies reporting the incidence of mortality, major adverse cardiovascular outcomes (MACE), progression to chronic kidney disease, or diabetes following adrenalectomy vs medical therapy were selected. Two reviewers independently abstracted data and assessed study quality. Standard meta-analyses were conducted using random-effects models to estimate relative differences. Time to benefit meta-analyses were conducted by fitting Weibull survival curves to estimate absolute risk differences and pooled using random-effects models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>15 541 patients (16 studies) with PA were included. Surgery was consistently associated with an overall lower risk of death (hazard ratio [HR] 0.34, 95% CI 0.22-0.54) and MACE (HR 0.55, 95% CI 0.36-0.84) compared with medical therapy. Surgery was associated with a significantly lower risk of hospitalization for heart failure (HR 0.48 95% CI 0.34-0.70) and progression to chronic kidney disease (HR 0.62 95% CI 0.39-0.98), and nonsignificant reductions in myocardial infarction and stroke. In absolute terms, 200 patients would need to be treated with surgery instead of medical therapy to prevent 1 death after 12.3 (95% CI 3.1-48.7) months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Surgery is associated with lower all-cause mortality and MACE than medical therapy for PA. For most patients, the long-term surgical benefits outweigh the short-term perioperative risks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgad654","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:21:35Z","timestamp":1699316495000},"page":"e1280-e1289","source":"Crossref","is-referenced-by-count":50,"title":["Time to Benefit of Surgery vs Targeted Medical Therapy for Patients With Primary Aldosteronism: A Meta-analysis"],"prefix":"10.1210","volume":"109","author":[{"given":"Sunil","family":"Samnani","sequence":"first","affiliation":[{"name":"Department of Medicine, Cumming School of Medicine, University of Calgary , Calgary, AB T2T 5C7 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Cenzer","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Department of Medicine, University of California (SanFrancisco) , San Francisco, CA 94121 , USA"},{"name":"Geriatrics, Palliative and Extended Care Service Line, SanFrancisco VA (Veterans Affairs) Health Care System , San Francisco, CA 94121 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A","family":"Kline","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cumming School of Medicine, University of Calgary , Calgary, AB T2T 5C7 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei J","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Department of Medicine, University of California (SanFrancisco) , San Francisco, CA 94121 , USA"},{"name":"Geriatrics, Palliative and Extended Care Service Line, SanFrancisco VA (Veterans Affairs) Health Care System , San Francisco, CA 94121 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L","family":"Hundemer","sequence":"additional","affiliation":[{"name":"Department of Medicine (Division of Nephrology) and the Ottawa Hospital Research Institute, University of Ottawa , Ottawa, ON K1H 7W9 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"McClurg","sequence":"additional","affiliation":[{"name":"Library and Cultural Resources, University of Calgary , Calgary, AB T2N 4N1 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2753-4988","authenticated-orcid":false,"given":"Janice L","family":"Pasieka","sequence":"additional","affiliation":[{"name":"Departments of Surgery and Oncology, University of Calgary , Calgary, AB T2N 2T9 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W John","family":"Boscardin","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, Department of Medicine, University of California (SanFrancisco) , San Francisco, CA 94121 , USA"},{"name":"Department of Epidemiology and Biostatistics, University of California (SanFrancisco) , San Francisco, CA 94158 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E","family":"Ronksley","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences, Cumming School of Medicine, University of Calgary , Calgary, AB T2N 4Z6 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7536-8497","authenticated-orcid":false,"given":"Alexander A","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cumming School of Medicine, University of Calgary , Calgary, AB T2T 5C7 , Canada"},{"name":"Department of Community Health Sciences, Cumming School of Medicine, University of Calgary , Calgary, AB T2N 4Z6 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"issue":"1","key":"2024022001150619400_dgad654-B1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"issue":"1","key":"2024022001150619400_dgad654-B2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"issue":"3","key":"2024022001150619400_dgad654-B3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/jc.2008-1851","article-title":"Risk factors associated with a low glomerular filtration rate in primary aldosteronism","volume":"94","author":"Reincke","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024022001150619400_dgad654-B4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2024022001150619400_dgad654-B5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"2024022001150619400_dgad654-B6","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024022001150619400_dgad654-B7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"issue":"8","key":"2024022001150619400_dgad654-B8","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"2024022001150619400_dgad654-B9","first-page":"274","article-title":"Cardiovascular changes in patients with primary aldosteronism after surgical or medical treatment","volume":"35","author":"Bernini","year":"2012","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2024022001150619400_dgad654-B10","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/jc.2013-2180","article-title":"Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases","volume":"99","author":"Iwakura","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2024022001150619400_dgad654-B11","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1245\/s10434-013-2871-3","article-title":"Medical or surgical therapy for primary aldosteronism: post-treatment follow-up as a surrogate measure of comparative outcomes","volume":"20","author":"Kline","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"2024022001150619400_dgad654-B12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/bjs.9744","article-title":"Systematic review of surgery and outcomes in patients with primary aldosteronism","volume":"102","author":"Muth","year":"2015","journal-title":"Br J Surg"},{"issue":"3","key":"2024022001150619400_dgad654-B13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0031-1299681","article-title":"Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review","volume":"44","author":"Steichen","year":"2012","journal-title":"Horm Metab Res"},{"issue":"3","key":"2024022001150619400_dgad654-B14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/j.ackd.2014.10.003","article-title":"Outcomes of drug-based and surgical treatments for primary aldosteronism","volume":"22","author":"Steichen","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"issue":"5","key":"2024022001150619400_dgad654-B15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"issue":"6","key":"2024022001150619400_dgad654-B16","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1055\/s-0029-1246185","article-title":"Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism","volume":"42","author":"Catena","year":"2010","journal-title":"Horm Metab Res"},{"issue":"5","key":"2024022001150619400_dgad654-B17","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024022001150619400_dgad654-B18","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4158\/EP161717.RA","article-title":"An individualized approach to the evaluation and management of primary aldosteronism","volume":"23","author":"Vaidya","year":"2017","journal-title":"Endocr Pract"},{"key":"2024022001150619400_dgad654-B19","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2024022001150619400_dgad654-B20","author":"Samnani"},{"issue":"1","key":"2024022001150619400_dgad654-B21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"1","key":"2024022001150619400_dgad654-B22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"2024022001150619400_dgad654-B23","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.cct.2008.06.002","article-title":"Estimating the relative hazard by the ratio of logarithms of event-free proportions","volume":"29","author":"Perneger","year":"2008","journal-title":"Contemp Clin Trials"},{"issue":"3","key":"2024022001150619400_dgad654-B24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/JU.0000000000000463","article-title":"The impact of nocturia on mortality: a systematic review and meta-analysis","volume":"203","author":"Pesonen","year":"2020","journal-title":"J Urol"},{"key":"2024022001150619400_dgad654-B25","doi-asserted-by":"crossref","first-page":"n189","DOI":"10.1136\/bmj.n189","article-title":"Association between antihypertensive treatment and adverse events: systematic review and meta-analysis","volume":"372","author":"Albasri","year":"2021","journal-title":"BMJ"},{"key":"2024022001150619400_dgad654-B26"},{"issue":"7109","key":"2024022001150619400_dgad654-B27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"10","key":"2024022001150619400_dgad654-B28","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","article-title":"Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry","volume":"61","author":"Peters","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"2024022001150619400_dgad654-B29","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/ije\/dyac073","article-title":"E-values for effect heterogeneity and approximations for causal interaction","volume":"51","author":"Mathur","year":"2022","journal-title":"Int J Epidemiol"},{"issue":"1","key":"2024022001150619400_dgad654-B30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-publhealth-051920-114020","article-title":"Methods to address confounding and other biases in meta-analyses: review and recommendations","volume":"43","author":"Mathur","year":"2022","journal-title":"Annu Rev Public Health"},{"issue":"4","key":"2024022001150619400_dgad654-B31","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/1536867X1801700402","article-title":"Reconstructing time-to-event data from published Kaplan-Meier curves","volume":"17","author":"Wei","year":"2017","journal-title":"Stata J"},{"issue":"1","key":"2024022001150619400_dgad654-B32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/jamainternmed.2021.6745","article-title":"Time to benefit of bisphosphonate therapy for the prevention of fractures among postmenopausal women with osteoporosis: a meta-analysis of randomized clinical trials","volume":"182","author":"Deardorff","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"5","key":"2024022001150619400_dgad654-B33","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/jgs.17684","article-title":"Time to benefit for stroke reduction after blood pressure treatment in older adults: a meta-analysis","volume":"70","author":"Ho","year":"2022","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"2024022001150619400_dgad654-B34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jamainternmed.2020.6084","article-title":"Evaluation of time to benefit of statins for the primary prevention of cardiovascular events in adults aged 50 to 75 years: a meta-analysis","volume":"181","author":"Yourman","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2024022001150619400_dgad654-B35","doi-asserted-by":"crossref","first-page":"h1662","DOI":"10.1136\/bmj.h1662","article-title":"Time to benefit for colorectal cancer screening: survival meta-analysis of flexible sigmoidoscopy trials","volume":"350","author":"Tang","year":"2015","journal-title":"BMJ"},{"key":"2024022001150619400_dgad654-B36","doi-asserted-by":"crossref","first-page":"e8441","DOI":"10.1136\/bmj.e8441","article-title":"Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark","volume":"346","author":"Lee","year":"2013","journal-title":"BMJ"},{"issue":"3","key":"2024022001150619400_dgad654-B37","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s12020-022-03029-4","article-title":"Evolution of the cardiometabolic profile of primary hyperaldosteronism patients treated with adrenalectomy and with mineralocorticoid receptor antagonists: results from the SPAIN-ALDO registry","volume":"76","author":"Araujo-Castro","year":"2022","journal-title":"Endocrine"},{"issue":"2","key":"2024022001150619400_dgad654-B38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.surg.2019.08.017","article-title":"Surgery decreases the long-term incident stroke risk in patients with primary aldosteronism","volume":"167","author":"Chang","year":"2020","journal-title":"Surgery"},{"issue":"6","key":"2024022001150619400_dgad654-B39","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1210\/js.2019-00019","article-title":"Adrenalectomy improves the long-term risk of end-stage renal disease and mortality of primary aldosteronism","volume":"3","author":"Chen","year":"2019","journal-title":"J Endocr Soc"},{"issue":"8","key":"2024022001150619400_dgad654-B40","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"3","key":"2024022001150619400_dgad654-B41","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal outcomes in medically and surgically treated primary aldosteronism","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension"},{"issue":"6","key":"2024022001150619400_dgad654-B42","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1161\/HYPERTENSIONAHA.120.16909","article-title":"Time-dependent risk of atrial fibrillation in patients with primary aldosteronism after medical or surgical treatment initiation","volume":"77","author":"Kim","year":"2021","journal-title":"Hypertension"},{"issue":"1","key":"2024022001150619400_dgad654-B43","doi-asserted-by":"crossref","first-page":"6925","DOI":"10.1038\/s41598-021-86290-3","article-title":"Age-stratified comparison of clinical outcomes between medical and surgical treatments in patients with unilateral primary aldosteronism","volume":"11","author":"Nakamaru","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"2024022001150619400_dgad654-B44","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1507\/endocrj.EJ16-0530","article-title":"Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism","volume":"64","author":"Park","year":"2017","journal-title":"Endocr J"},{"issue":"2","key":"2024022001150619400_dgad654-B45","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/cen.14351","article-title":"Outcomes in unilateral primary aldosteronism after surgical or medical therapy","volume":"94","author":"Puar","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2024022001150619400_dgad654-B46","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational study mortality in treated primary aldosteronism: the German Conn's Registry","volume":"60","author":"Reincke","year":"2012","journal-title":"Hypertension"},{"issue":"4","key":"2024022001150619400_dgad654-B47","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.117.10596","article-title":"Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism patients at long term","volume":"71","author":"Rossi","year":"2018","journal-title":"Hypertension"},{"issue":"2","key":"2024022001150619400_dgad654-B48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/EJE-21-0836","article-title":"Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments","volume":"186","author":"Wu","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2024022001150619400_dgad654-B49","doi-asserted-by":"crossref","first-page":"32103","DOI":"10.1038\/srep32103","article-title":"Long term outcome of aldosteronism after target treatments","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"2024022001150619400_dgad654-B50","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"6","key":"2024022001150619400_dgad654-B51","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41440-019-0244-4","article-title":"Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism","volume":"42","author":"Satoh","year":"2019","journal-title":"Hypertens Res"},{"issue":"6","key":"2024022001150619400_dgad654-B52","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1530\/EJE-22-0375","article-title":"Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysis","volume":"187","author":"Chen","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"2024022001150619400_dgad654-B53","doi-asserted-by":"crossref","first-page":"644260","DOI":"10.3389\/fendo.2021.644260","article-title":"Composite cardiovascular outcomes in patients with primary aldosteronism undergoing medical versus surgical treatment: a meta-analysis","volume":"12","author":"Huang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2024022001150619400_dgad654-B54","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijcard.2016.01.200","article-title":"Cardiovascular risk markers in patients with primary aldosteronism: a systematic review and meta-analysis of literature studies","volume":"208","author":"Ambrosino","year":"2016","journal-title":"Int J Cardiol"},{"issue":"9","key":"2024022001150619400_dgad654-B55","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/HYPERTENSIONAHA.122.17964","article-title":"Aldosterone as a mediator of cardiovascular damage","volume":"79","author":"Buffolo","year":"2022","journal-title":"Hypertension"},{"issue":"1","key":"2024022001150619400_dgad654-B56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajh\/hpaa137","article-title":"Aldosterone, inflammation, immune system, and hypertension","volume":"34","author":"Ferreira","year":"2021","journal-title":"Am J Hypertens"},{"issue":"10","key":"2024022001150619400_dgad654-B57","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"issue":"5","key":"2024022001150619400_dgad654-B58","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/HJH.0b013e3283455ca5","article-title":"A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism","volume":"29","author":"Parthasarathy","year":"2011","journal-title":"J Hypertens"},{"key":"2024022001150619400_dgad654-B59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ahj.2017.03.011","article-title":"True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: A meta-analysis","volume":"188","author":"Vukadinovic","year":"2017","journal-title":"Am Heart J"},{"issue":"5","key":"2024022001150619400_dgad654-B60","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa2213169","article-title":"Phase 2 trial of baxdrostat for treatment-resistant hypertension","volume":"388","author":"Freeman","year":"2023","journal-title":"N Engl J Med"},{"issue":"9","key":"2024022001150619400_dgad654-B61","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan endocrine society 2009","volume":"58","author":"Nishikawa","year":"2011","journal-title":"Endocr J"},{"issue":"3","key":"2024022001150619400_dgad654-B62","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ando.2016.01.009","article-title":"SFE\/SFHTA\/AFCE consensus on primary aldosteronism, part 6: adrenal surgery","volume":"77","author":"Steichen","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"issue":"10","key":"2024022001150619400_dgad654-B63","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/jamasurg.2022.3544","article-title":"American Association of endocrine surgeons guidelines for adrenalectomy: executive summary","volume":"157","author":"Yip","year":"2022","journal-title":"JAMA Surg"},{"issue":"5","key":"2024022001150619400_dgad654-B64","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/000313481508100534","article-title":"Elective laparoscopic adrenalectomy outcomes in 1099 ACS NSQIP patients: identifying candidates for early discharge","volume":"81","author":"Turrentine","year":"2015","journal-title":"Am Surg"},{"issue":"11","key":"2024022001150619400_dgad654-B65","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamasurg.2018.2648","article-title":"Risk factors associated with perioperative complications and prolonged length of stay after laparoscopic adrenalectomy","volume":"153","author":"Chen","year":"2018","journal-title":"JAMA Surg"},{"issue":"24","key":"2024022001150619400_dgad654-B66","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/jama.2013.282612","article-title":"Incorporating lag time to benefit into prevention decisions for older adults","volume":"310","author":"Lee","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"2024022001150619400_dgad654-B67","doi-asserted-by":"crossref","first-page":"39f","DOI":"10.1016\/j.amjcard.2005.06.025","article-title":"Different time course for prevention of coronary and stroke events by atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA)","volume":"96","author":"Sever","year":"2005","journal-title":"Am J Cardiol"},{"issue":"6","key":"2024022001150619400_dgad654-B68","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1503\/cmaj.080484","article-title":"The \u201cnumber needed to treat\u201d turns 20--and continues to be used and misused","volume":"179","author":"McAlister","year":"2008","journal-title":"CMAJ"},{"issue":"4","key":"2024022001150619400_dgad654-B69","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/ajh\/hpab195","article-title":"External validation of clinical prediction models in unilateral primary aldosteronism","volume":"35","author":"Sam","year":"2022","journal-title":"Am J Hypertens"},{"issue":"1","key":"2024022001150619400_dgad654-B70","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41591-022-02114-5","article-title":"[(11)C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial","volume":"29","author":"Wu","year":"2023","journal-title":"Nat Med"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgad654\/53652148\/dgad654.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/3\/e1280\/56680999\/dgad654.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/3\/e1280\/56680999\/dgad654.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T20:19:24Z","timestamp":1708373964000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/3\/e1280\/7381064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":70,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,11,8]]},"published-print":{"date-parts":[[2024,2,20]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgad654","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2023,11,8]]}}}